sicklecellanemianews48 分钟
SCD patients free of VOEs after treatment with gene-editing therapy
Nearly all the patients with severe SCD treated with the gene-editing therapy reni-cel remained free of VOEs for up to two ...
precisionmedicineonline47 分钟
Vittoria Biotherapeutics Hoping to Fast-Track Development of Novel CAR T-Cell Therapy
The company is using its Senza5 platform to produce CAR T cells without the CD5 receptor, hoping to enable smaller doses and avoid CAR-T fratricide.